Plain-English translation of NCT06468852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing Goal-Directed Fluid Therapy (GDFT)—a precise, technology-guided way of managing the fluids doctors give you through an IV during head and neck cancer surgery. Instead of using a one-size-fits-all approach, GDFT uses monitoring devices to adjust your fluids in real time, with the goal of reducing serious complications after surgery and helping you go home faster.
After major surgery, many patients develop serious complications that extend hospital stays and affect recovery. This medication has already shown promise in other types of major surgery, but doctors aren't yet sure whether it works as well for head and neck cancer surgery specifically.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would undergo your planned head and neck cancer surgery at Beijing Tongren Hospital. During surgery, you would receive either the new fluid management approach or standard fluid management. The GDFT approach involves continuous monitoring of your heart's output and fluid status with devices, and your IV fluids would be adjusted automatically every 5 minutes based on these readings to keep your body in optimal balance. Your participation ends after you leave the hospital, with follow-up to track any complications.
AI-generated summary from trial data · Jul 6, 2026 · Not medical advice
China